Impact Therapeutics files Senaparib for EU final marketing authorization
Impact Therapeutics says Senaparib has been submitted to the European Commission for a final marketing authorization decision.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.